Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Identification of two microRNA nodes as potential cooperative modulators of liver metabolism.

Hochreuter MY, Altıntaş A, Garde C, Emanuelli B, Kahn CR, Zierath JR, Vienberg S, Barrès R.

Hepatol Res. 2019 Aug 13. doi: 10.1111/hepr.13419. [Epub ahead of print]

PMID:
31408567
2.

Association Between Index of Nutritional Quality and Nonalcoholic Fatty Liver Disease: The Role of Vitamin D and B Group.

Vahid F, Hekmatdoost A, Mirmajidi S, Doaei S, Rahmani D, Faghfoori Z.

Am J Med Sci. 2019 Jul 1. pii: S0002-9629(19)30258-7. doi: 10.1016/j.amjms.2019.06.008. [Epub ahead of print]

PMID:
31326093
3.

Zinc oxide nanoparticles attenuate hepatic steatosis development in high-fat-diet fed mice through activated AMPK signaling axis.

Dogra S, Kar AK, Girdhar K, Daniel PV, Chatterjee S, Choubey A, Ghosh S, Patnaik S, Ghosh D, Mondal P.

Nanomedicine. 2019 Apr;17:210-222. doi: 10.1016/j.nano.2019.01.013. Epub 2019 Jan 30.

PMID:
30708053
4.

Effect of nanoformulated copper/zinc superoxide dismutase on chronic ethanol-induced alterations in liver and adipose tissue.

Natarajan G, Perriotte-Olson C, Casey CA, Donohue TM Jr, Talmon GA, Harris EN, Kabanov AV, Saraswathi V.

Alcohol. 2019 Jan 3;79:71-79. doi: 10.1016/j.alcohol.2018.12.005. [Epub ahead of print]

PMID:
30611703
5.

JAZF1 ameliorates age and diet-associated hepatic steatosis through SREBP-1c -dependent mechanism.

Wei Q, Zhou B, Yang G, Hu W, Zhang L, Liu R, Li M, Wang K, Gu HF, Guan Y, Zhu Z, Zheng H, Peng J, Li L.

Cell Death Dis. 2018 Aug 28;9(9):859. doi: 10.1038/s41419-018-0923-0.

6.

Evaluation of Plasma Trace Elements in Different Stages of Nonalcoholic Fatty Liver Disease.

Asprouli E, Kalafati IP, Sakellari A, Karavoltsos S, Vlachogiannakos J, Revenas K, Kokkinos A, Dassenakis M, Dedoussis GV, Kalogeropoulos N.

Biol Trace Elem Res. 2019 Apr;188(2):326-333. doi: 10.1007/s12011-018-1432-9. Epub 2018 Jul 16.

PMID:
30014284
7.

Insulin/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis.

Liu Y, Jiang L, Sun C, Ireland N, Shah YM, Liu Y, Rui L.

Nat Commun. 2018 Jul 16;9(1):2751. doi: 10.1038/s41467-018-05309-y.

8.

Zinc alpha2 glycoprotein protects against obesity-induced hepatic steatosis.

Xiao XH, Wang YD, Qi XY, Wang YY, Li JY, Li H, Zhang PY, Liao HL, Li MH, Liao ZZ, Yang J, Xu CX, Wen GB, Liu JH.

Int J Obes (Lond). 2018 Aug;42(8):1418-1430. doi: 10.1038/s41366-018-0151-9. Epub 2018 Jul 13.

PMID:
30006580
9.

Expression of zinc transporters ZIP4, ZIP14 and ZnT9 in hepatic carcinogenesis-An immunohistochemical study.

Gartmann L, Wex T, Grüngreiff K, Reinhold D, Kalinski T, Malfertheiner P, Schütte K.

J Trace Elem Med Biol. 2018 Sep;49:35-42. doi: 10.1016/j.jtemb.2018.04.034. Epub 2018 Apr 27.

PMID:
29895370
10.

Effect of high chronic intake of sucrose on liver metabolism in aging rats. Modulation by rutin and micronutrients.

Gatineau E, Capel F, Dardevet D, David J, Pouyet C, Polakof S, Mosoni L.

J Physiol Biochem. 2018 Nov;74(4):569-577. doi: 10.1007/s13105-018-0628-y. Epub 2018 Apr 10.

PMID:
29637446
11.

Canagliflozin protects against non-alcoholic steatohepatitis in type-2 diabetic rats through zinc alpha-2 glycoprotein up-regulation.

Kabil SL, Mahmoud NM.

Eur J Pharmacol. 2018 Jun 5;828:135-145. doi: 10.1016/j.ejphar.2018.03.043. Epub 2018 Mar 30.

PMID:
29608898
12.

Nutritional Status and Nutrition Quality in Patients with Non-Alcoholic Fatty Liver Disease.

Vranešić Bender D, Nutrizio M, Jošić M, Ljubas Kelečić D, Karas I, Premužić M, Domislović V, Rotim C, Krznarić Ž.

Acta Clin Croat. 2017 Dec;56(4):625-634. doi: 10.20471/acc.2017.56.04.07.

PMID:
29590715
13.

Prevalence of fat-soluble vitamin (A, D, and E) and zinc deficiency in patients with cirrhosis being assessed for liver transplantation.

Teriaky A, Mosli M, Chandok N, Al-Judaibi B, Marotta P, Qumosani K.

Acta Gastroenterol Belg. 2017 Apr-Jun;80(2):237-241.

PMID:
29560688
14.
15.

Serum Antioxidant Associations with Metabolic Characteristics in Metabolically Healthy and Unhealthy Adolescents with Severe Obesity: An Observational Study.

Stenzel AP, Carvalho R, Jesus P, Bull A, Pereira S, Saboya C, Ramalho A.

Nutrients. 2018 Jan 30;10(2). pii: E150. doi: 10.3390/nu10020150.

16.

Hepatic ZIP14-mediated zinc transport is required for adaptation to endoplasmic reticulum stress.

Kim MH, Aydemir TB, Kim J, Cousins RJ.

Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):E5805-E5814. doi: 10.1073/pnas.1704012114. Epub 2017 Jul 3.

17.

Human germline hedgehog pathway mutations predispose to fatty liver.

Guillen-Sacoto MJ, Martinez AF, Abe Y, Kruszka P, Weiss K, Everson JL, Bataller R, Kleiner DE, Ward JM, Sulik KK, Lipinski RJ, Solomon BD, Muenke M.

J Hepatol. 2017 Oct;67(4):809-817. doi: 10.1016/j.jhep.2017.06.008. Epub 2017 Jun 21.

18.

Zinc and Selenium Co-supplementation Reduces Some Lipid Peroxidation and Angiogenesis Markers in a Rat Model of NAFLD-Fed High Fat Diet.

Mousavi SN, Faghihi A, Motaghinejad M, Shiasi M, Imanparast F, Amiri HL, Shidfar F.

Biol Trace Elem Res. 2018 Feb;181(2):288-295. doi: 10.1007/s12011-017-1059-2. Epub 2017 Jun 2.

PMID:
28577233
19.

Palmitic acid elicits hepatic stellate cell activation through inflammasomes and hedgehog signaling.

Duan NN, Liu XJ, Wu J.

Life Sci. 2017 May 1;176:42-53. doi: 10.1016/j.lfs.2017.03.012. Epub 2017 Mar 18.

PMID:
28322865
20.

Association between soil heavy metals and fatty liver disease in men in Taiwan: a cross sectional study.

Lin YC, Lian IB, Kor CT, Chang CC, Su PY, Chang WT, Liang YF, Su WW, Soon MS.

BMJ Open. 2017 Jan 23;7(1):e014215. doi: 10.1136/bmjopen-2016-014215.

Supplemental Content

Loading ...
Support Center